4.6 Article

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

Journal

JOURNAL OF IMMUNOLOGY
Volume 169, Issue 10, Pages 6020-6029

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.169.10.6020

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [AI 42753] Funding Source: Medline
  2. NIAMS NIH HHS [AR 42525, 1P30 AR 48310] Funding Source: Medline
  3. NIA NIH HHS [AG 014783] Funding Source: Medline
  4. NIEHS NIH HHS [ES 011196-02] Funding Source: Medline

Ask authors/readers for more resources

Individuals with systemic Inputs erythematosus show evidence of a significant increase in monocyte apoptosis. This process is mediated, at least in part, by an autoreactive T cell subset that kills autologous monocytes in the absence of nominal Ag. We have investigated the apoptotic pathways involved in this T cell-mediated process. Expression of the apoptotic ligands TRAIL, TNF-like weak inducer of apoptosis (TWEAK), and Fas ligand on lupus T cells was determined, and the role of these molecules in the monocyte apoptotic response was examined. We report that these apoptotic ligands mediate the autologous monocyte death induced. by Inputs T cells and that this cytotoxicity is associated with increased expression of these molecules on activated T cells, rather than with an increased susceptibility of lupus monocytes to apoptosis induced by these ligands. These results define novel mechanisms that contribute to increased monocyte apoptosis characterizing patients with lupus. We propose that this mechanism could provide a source of potentially antigenic material for the autoimmune response and interfere with - normal clearing mechanisms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available